Ziopharm Oncology is refreshing its CEO post with a new leader, nabbing former Kuur Therapeutics CEO Kevin S. Boyle for the top spot. The cell and gene therapies biotech also promoted Chief

A series of chief medical officers have hit the exits over the past month, with biotechs such as Black Diamond Therapeutics, Replimune and Avidity Biosciences all disclosing departures in recent

Oncology biotech Exelixis is mourning the deaths of two key members of its company after losing its sales leader and CMO in the same week. Gisela Schwab, M.D., the company’s

It’s lucky number seven for Medable. The decentralized clinical trials technology company has hired MaryAnne Rizk, Ph.D., as chief strategy officer to lead global partnerships in a year filled with

NovaRock Biotherapeutics is taking its antibody programs global through a new partnership. For $7.5 million upfront and a potential $633 million in milestones, the New Jersey-based biotech is licensing a

The FDA issued its first green light for an at-home COVID-19 diagnostic that delivers results through the user’s smartphone, streamlining self-testing for students and employees as they begin to return

Ontada has access to a treasure trove of data from more than 2,000 oncology providers, and Merck wants to tap into the insights business.  Merck will work with McKesson’s Ontada

With regular venture funding rounds and a handful of new strategic partnerships and technology launches in recent years, expanding the reach of its telegenomics service platform has become a core

The FDA approved its first nerve stimulation device designed to help people suffering from the lasting effects of stroke to gradually regain control of their arms and hands. Developed by

A newly developed 3D-printable tissue scaffold is designed to break down in the body once it has served its medical purpose. The 4Degra biodegradable and customizable biomaterial could provide support for healing

TU Dresden scientists at the Chair of Optoelectronics have now succeeded for the first time in developing a bio-compatible implantable AI platform that classifies in real time healthy and pathological

Johnson & Johnson’s CEO, Alex Gorsky said he would be stepping down from the role Ina. 3, 2022, citing family reasons. Gorsky will serve as executive chairman Johnson & Johnson

Traditional methods to treat cardiac arrhythmias typically see cardiologists inserting a catheter into the heart to measure electrical impulses and determine where in the tissue the abnormal rhythm is originating—often

AbbVie’s medical aesthetics division Allergan may not get the makeover it was counting on this year if the Federal Trade Commission (FTC) has anything to say about it. The FTC has

Making good on its pledge to expand reach of Project Baseline, its clinical research platform, Verily is set to acquire North Carolina-based software developer SignalPath. Like Baseline, SignalPath’s eponymous platform aims to